Clinical Trials

100 enrolled

Lung Neoplasms, Neoplasm, Residual

NCT01499394 2026-01-21

Caris Biorepository Research Protocol

100,000 enrolled

Neoplasms, Neoplasm, Residual

NCT07356882 2026-01-21

EURHOLY

400 enrolled

Neoplasm, Residual

NCT05595408 2025-12-09

Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper Tract Urothelial Carcinoma

84 enrolled

Neoplasm, Residual

NCT06287749 2025-07-10

French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)

37 enrolled

Neoplasm, Residual

NCT06287814 2025-07-10

French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC)

70 enrolled

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms, Neoplasm, Residual

NCT05196087 2025-07-02

NIP IT!

BreastDermatologicEndocrineGastrointestinalNET

500 enrolled

Gastro-enteropancreatic neuroendocrine tumor, Breast Neoplasms, Melanoma, Neoplasm, Residual

NCT06963307 2025-05-09

LumenDx

300 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm, Residual

NCT05959720 2025-05-07

BRALLA

LymphoidOther hematologic neoplasm

180 enrolled

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05198154 2025-04-23

CR1STAL

100 enrolled

Neoplasm, Residual

NCT06111105 2025-03-30

GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing CtDNA Diagnostics - Colorectal Cancer

590 enrolled

Gastrointestinal

Colorectal Neoplasms, Neoplasm, Residual

NCT06875609 2025-03-26

ctDNA in Cutaneous Squamous Cell Carcinoma

60 enrolled

Dermatologic

Skin Neoplasms, Neoplasm, Residual

NCT06230185 2025-01-07

B-STRONGER-I

422 enrolled

Breast

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT04466059 2024-12-17

BELUGA

LymphoidOther hematologic neoplasm

25,000 enrolled

Leukemia, Lymphoma, Neoplasm, Residual, Hematologic Neoplasms

NCT05203003 2024-12-06

MRD-CONFIRM

260 enrolled

Multiple Myeloma, Neoplasm, Residual

NCT06595966 2024-09-19

Exploratory Research on Constructing a Computational Biological Model Based on NGS for MRD After Breast Cancer Surgery

80 enrolled

Breast

Breast Neoplasms, Neoplasm, Residual

NCT06514118 2024-07-23

Chemoimmunotherapy Plus Residual Lesion Irradiation for the Treatment of Extensive Stage Small-cell Lung Cancer

70 enrolled

Neoplasm, Residual, Small Cell Lung Carcinoma

NCT06109233 2024-07-05

MRD

80 enrolled

Multiple Myeloma, Neoplasm, Residual

NCT06463717 2024-06-24

Primary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or Not

210 enrolled

Multiple Myeloma, Neoplasm, Residual

NCT06302699 2024-03-12

Detecting Minimal Residual Diseases (MRD) and Monitoring Clonal Evolution Using Ultrasensitive Chromosomal Aberrations Detection (UCAD) in Multiple Myeloma

80 enrolled

Multiple Myeloma, Neoplasm, Residual

NCT02306096 2024-02-09

SCAN-B

20,000 enrolled

Breast

Breast Neoplasms, Neoplastic Cells, Circulating, Neoplasm, Residual

NCT06198868 2024-01-12

MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC

60 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasm, Residual

NCT05952661 2023-07-19

ECMRD-001

56 enrolled

Gastrointestinal

Esophageal Neoplasms, Neoplasm, Residual

NCT05867901 2023-05-31

Clinical Research of Drug Holiday Based on MRD Detection in GIST Patients at High Risk of Recurrence

40 enrolled

GastrointestinalSarcoma

Neoplasm, Residual, Gastrointestinal Stromal Tumors

NCT05408897 2022-09-21

Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD